Aims and Scope of Journal of Medical Economics
The Journal of Medical Economics is a monthly peer-reviewed academic journal that covers econometric assessments of novel therapeutic and medical device interventions. It is published by Routledge and was established in 1998. The editor-in-chief is K. Lee. Less
Key Metrics
CiteScore 

3.7
H-Index 

52
Impact Factor 

< 5
SJR 

Q2Health Policy

SNIP 

0.86
Recommended pre-submission checks
Powered by 

Topics Covered on Journal of Medical Economics
Journal of Medical Economics Journal Specifications
| Overview | |
| Publisher | TAYLOR & FRANCIS LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Journal of Medical Economics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Journal of Medical Economics
Plain language summary looking at the impact of drug management strategies on the incidence and cost of clinical events in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the USA
- 31 Dec 2026
- Journal of Medical Economics
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison
- 31 Dec 2026
- Journal of Medical Economics
CPAP treatment persistence following nasal procedures in obstructive sleep apnea: a real-world claims-based analysis of 1.3 million patients
- 31 Dec 2026
- Journal of Medical Economics
Cost-effectiveness and budget impact of PFO closure: Cardioform vs Amplatzer and medical therapy for secondary stroke prevention in Australia
- 31 Dec 2026
- Journal of Medical Economics
Return on investment of national specific health guidance in Japan: an observational study using “Wellness-Star⋆” health insurance claims database
- 31 Dec 2026
- Journal of Medical Economics
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis
- 31 Dec 2026
- Journal of Medical Economics
Plain language summary looking at the impact of drug management strategies on the incidence and cost of clinical events in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the USA
- 31 Dec 2026
- Journal of Medical Economics
Cost-effectiveness of pembrolizumab plus chemotherapy for metastatic non-small cell lung cancer: a head-to-head trial vs. real-world comparison
- 31 Dec 2026
- Journal of Medical Economics
CPAP treatment persistence following nasal procedures in obstructive sleep apnea: a real-world claims-based analysis of 1.3 million patients
- 31 Dec 2026
- Journal of Medical Economics
Cost-effectiveness and budget impact of PFO closure: Cardioform vs Amplatzer and medical therapy for secondary stroke prevention in Australia
- 31 Dec 2026
- Journal of Medical Economics
Return on investment of national specific health guidance in Japan: an observational study using “Wellness-Star⋆” health insurance claims database
- 31 Dec 2026
- Journal of Medical Economics
Bleeding rates, healthcare utilization, and costs among patients with hemophilia a without inhibitors treated with concomitant octocog alfa or extended half-life factor VIII while on emicizumab prophylaxis
- 31 Dec 2026
- Journal of Medical Economics